As faculty in the College of Pharmacy at Purdue University, Dr. Matosevic leads an active, externally-funded research program in immunotherapy with natural killer cells. He has made important contributions to the field of NK cell immunotherapy and continues to study their reprogramming in the microenvironment of tumors and how this can be overcome to advance their use in the clinic. Dr. Matosevic has extensive experience in cell-based therapies with NK cells. Apart from a prolific research output, he has led important initiatives in cell therapy, aimed at standardizing cell-based therapy development and manufacturing with ISO and USP, as well as having organized and co-chaired a workshop at the National Institute of Standards and Technology with an international audience of academic and industrial stakeholders. He has acted on the Communications Committee of the International Society for Cellular Therapy and continue to organize and chair academic meetings on natural killer cell-based therapies.